🇺🇸 FDA
Patent

US 8785410

Antisense composition and method for treating muscle atrophy

granted A61KA61K31/675A61K47/645

Quick answer

US patent 8785410 (Antisense composition and method for treating muscle atrophy) held by Sarepta Therapeutics, Inc. expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sarepta Therapeutics, Inc.
Grant date
Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/675, A61K47/645, A61P, A61P21/00